CN105412626A - 一种用于治疗颈椎骨质增生的药物制剂及其用途 - Google Patents
一种用于治疗颈椎骨质增生的药物制剂及其用途 Download PDFInfo
- Publication number
- CN105412626A CN105412626A CN201610013359.1A CN201610013359A CN105412626A CN 105412626 A CN105412626 A CN 105412626A CN 201610013359 A CN201610013359 A CN 201610013359A CN 105412626 A CN105412626 A CN 105412626A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- pharmaceutical preparation
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 210000000988 bone and bone Anatomy 0.000 title abstract description 7
- 206010020718 hyperplasia Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title description 5
- 241000903946 Clematidis Species 0.000 claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 241000270295 Serpentes Species 0.000 claims abstract description 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 33
- 206010005963 Bone formation increased Diseases 0.000 claims description 26
- 238000011282 treatment Methods 0.000 claims description 25
- 241000628997 Flos Species 0.000 claims description 15
- 241000237636 Pheretima Species 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000002674 ointment Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 239000011505 plaster Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 28
- 230000036407 pain Effects 0.000 abstract description 26
- 208000024891 symptom Diseases 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 14
- 230000001965 increasing effect Effects 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 238000009825 accumulation Methods 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 abstract description 2
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000094617 Coccoloba diversifolia Species 0.000 abstract 1
- 235000006653 Coccoloba diversifolia Nutrition 0.000 abstract 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 229930193974 gastrodin Natural products 0.000 abstract 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 abstract 1
- 230000008338 local blood flow Effects 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 230000017531 blood circulation Effects 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 12
- 208000006820 Arthralgia Diseases 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000002671 adjuvant Substances 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229940126701 oral medication Drugs 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 229920000881 Modified starch Polymers 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 208000005392 Spasm Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000036319 cervical spondylosis Diseases 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 208000005801 spondylosis Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000029761 vertebral disease Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 208000019669 cervical disc degenerative disease Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004574 high-performance concrete Substances 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗颈椎骨质增生的药物制剂及其用途,按照重量分数比包括:葛根6-18份,丹参6-18份,当归15-30份,川芎15-30份,红花15-30份,桃仁10-20份,元胡10-20份,千年健10-20份,羌活10-20份,乌鞘蛇10-15份,威灵仙15-25份,秦艽8-18份,苏木6-18份,补骨脂10-20份,狗脊8-20份,天麻10-15份,木防己12-25份,赤芍12-25份,地龙12-25份,鸡血藤12-25份。以上方药具有扩张血管、增加局部循环血量、改善关节周围循环及营养状况,使毛细血管渗出减少,关节及周围组织液体吸收加快等作用,使致痛物质堆积现象迅速得到解除,有利于功能的快速恢复。对消除颈椎增生的疼痛、缓解临床症状取效迅捷,标本兼治,愈后复发率低,且使用方便、无毒副作用、便于推广应用。
Description
技术领域
本发明属于中医药领域,尤其是涉及一种用于治疗颈椎骨质增生的药物制剂及其用途。
背景技术
颈椎病是临床上常见的疾病,是因颈椎间盘变性、颈椎骨质增生所引起的综合症。在颈椎病的发生发展中,慢性劳损是首要原因,主要由于颈椎长期劳损、骨质增生,或椎间盘脱出、韧带增厚,致使颈椎脊髓、神经根或椎动脉受压,出现一系列功能障碍的临床综合征。主要症状是头、颈、肩、背、手臂酸痛,颈脖子僵硬,活动受限,有的伴有头晕,重者伴有恶心呕吐,卧床不起。
颈椎骨质增生主要因职业因素、过度劳累,低头时间过长、风湿、寒冷刺激、外伤、咽喉慢性炎症等,导致血液循环不畅,椎体周围瘀血停滞、经络不通,有赘疣物质滋生。近年来,随着社会分工的转变,从事低头工作方式的人群在日益增多,使遭受风寒湿邪和屈颈的机会不断增加,在现阶段是我国临床上的一种多发和常见的疾病。
目前,公知的治疗颈椎骨质增生病的方法诸多,西医上具有牵引、止痛、手术的方法,对其病根不能彻底根除,中医上的辩证论治诸多,而具有显著效果的药物极少。
发明内容
本发明结合中医的对颈椎骨质增生的辩证,斟酌中药组方,调配了一种通经止痛,健脾疏肝,活血化瘀的有效地治疗颈椎骨质增生的药物制剂。
具体而言,本发明的技术方案是这样实现的:
一种用于治疗颈椎骨质增生的药物制剂,按照重量分数比包括:葛根6-18份,丹参6-18份,当归15-30份,川芎15-30份,红花15-30份,桃仁10-20份,元胡10-20份,千年健10-20份,羌活10-20份,乌鞘蛇10-15份,威灵仙15-25份,秦艽8-18份,苏木6-18份,补骨脂10-20份,狗脊8-20份,天麻10-15份,木防己12-25份,赤芍12-25份,地龙12-25份,鸡血藤12-25份。
为了进一步取得较好的技术效果,一种用于治疗颈椎骨质增生的药物制剂,优选地,以上各成分按照重量比为:
葛根15份,丹参15份,当归20份,川芎20份,红花20份,桃仁15份,元胡15份,千年健15份,羌活15份,乌鞘蛇12份,威灵仙20份,秦艽15份,苏木15份,补骨脂15份,狗脊15份,天麻12份,木防己20份,赤芍20份,地龙20份,鸡血藤20份。
为了进一步取得较好的技术效果,一种用于治疗颈椎骨质增生的药物制剂,优选地,以上各成分按照重量比为:
葛根12份,丹参12份,当归18份,川芎18份,红花18份,桃仁16份,元胡16份,千年健18份,羌活18份,乌鞘蛇12份,威灵仙22份,秦艽12份,苏木12份,补骨脂12份,狗脊12份,天麻12份,木防己15份,赤芍15份,地龙15份,鸡血藤15份。
一种用于治疗颈椎骨质增生的药物制剂,所述药物制剂在治疗颈椎骨质增生中的应用。
一种用于治疗颈椎骨质增生的药物制剂,所述药物制剂制备成膏药贴剂。
优选地,用于膏药贴剂时,用食醋调制膏剂。
一种用于治疗颈椎骨质增生的药物制剂,所述药物制剂制备成颗粒剂,散剂,胶囊剂,丸剂,片剂以及临床上可接受的剂型。
本发明药物制备不同剂型仅所用的成型工艺和辅料不同,药物有效成分还是一样的,治疗效果也相同或近似。颗粒剂的辅料可为庶糖粉、羟甲基纤维素钠、糊精及矫味剂等中进行选择;散剂可从淀粉、白陶土、磷酸钙、沉降碳酸钙等中选择;胶囊剂的辅料可从二氧化硅、蔗糖、HPC、微晶纤维素、预胶化淀粉、乳糖、糖粉、羧甲淀粉钠、羧甲纤维素钠、羟丙甲纤维素等中进行选择;丸剂的辅料可从淀粉、微晶纤维素、预胶化淀粉等中进行选择;片剂的辅料可从淀粉、糊精、微晶纤维素、预胶化淀粉、硬脂酸镁、乳糖、糖粉、羧甲淀粉钠等中进行选择。
本发明中所用到的中药的药理作用:
葛根,解表退热,生津,透疹,升阳止泻,促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤。丹参祛瘀止痛,活血通经,清心除烦。当归可补血活血,调经止痛,润肠通便,用于血虚萎黄、眩晕心悸、经闭痛经、虚寒腹痛、风湿痹痛、跌扑损伤、痈疽疮疡。川芎为行气药、祛风药、活血药;活血行气,适宜瘀血阻滞;祛风止痛,可治头风头痛、风湿痹痛,月经不调、经闭痛经、产后瘀滞腥痛、症瘕肿块、胸胁疼痛、头痛眩晕、跌打损伤;川芎为血中之气药,殆言其寓辛散、解郁、通达、止痛,风寒湿痹,痈疽疮疡。
红花,活血通经,祛瘀止痛;苏木与红花功用相近,均具活血祛瘀,通经止痛之效,且二者都可和血,破血,攻补兼施,红花性温,苏木性凉且能祛风,红花专治血分,苏木兼能散表里之风。桃仁活血祛瘀,破血行瘀,润燥滑肠的功效。元胡:活血,散瘀,理气,止痛,治心腹腰膝诸痛,崩中,产后血晕,月经不调,癥瘕,恶露不尽,跌打损伤。
千年健,祛风湿;舒筋活络;止痛;消肿。主风湿痹痛;肢节酸育;筋骨痿软;跌打损伤;胃痛;痈疽疮肿。祛风湿,健筋骨,活血止痛。羌活,散表寒,祛风湿,利关节,治感冒风寒,头痛无汗,风寒湿痹,项强筋急,骨节酸疼,风水浮肿,痈疽疮毒。乌鞘蛇,祛风,通络,止痉。用于风湿顽痹,麻木拘挛,中风口眼歪斜,半身不遂,抽搐痉挛,破伤风,麻风疥癣,瘰疬恶疮。威灵仙,其根及茎入药具有风湿、通经络、消骨哽之功效,在现代临床实践中其新的用途不断的被发现,如治疗胆结石,跟骨骨刺、足跟痛、食管癌等。秦艽,祛风湿;舒筋络;清虚热;利湿退黄,主风湿痹通痛;筋骨拘挛;手足不遂;骨蒸潮热;小儿疳热;湿热黄疸。
补骨脂具有温肾助阳,纳气,止泻的作用。狗脊,补肝肾,除风湿,健腰脚,利关节。治腰背酸疼,膝痛脚弱,寒湿周痹。天麻,祛风止痛,用于风痰引起的眩晕、偏正头痛、肢体麻木、半身不遂。木防己,祛风除湿;通经活络;解毒消肿。主风湿痹痛;水肿;小便淋痛;闭经;跌打损伤;咽喉肿痛;疮疡肿毒;湿疹;毒蛇咬伤。赤芍善于活血化瘀,通络止痛。地龙,清热平肝、熄风止痉、平喘、利尿、通络除痹,主治高热烦躁、惊痫抽搐、肺热喘咳、热结尿闭、痹痛肢麻、半身不遂,以及疮疡肿毒等证。鸡血藤,补血,活血,通络,用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛。
本方中以当归、川芎养血活血,通经止痛;桃仁、苏木、红花、丹参活血祛瘀,止痛消肿;赤芍、鸡血藤祛瘀行滞,舒筋活络;木防己、秦艽宣泄瘀滞,解肌挛痛,通利关节;天麻、威灵仙祛风湿,舒肩背、肢体之挛痛;千年健、羌活、地龙除湿、强筋骨、祛除寒湿痹痛。诸药协同,共奏活血祛瘀、祛风除湿、温经止痛之功。现代研究表明:以上方药具有扩张血管、增加局部循环血量、改善关节周围循环及营养状况,使毛细血管渗出减少,关节及周围组织液体吸收加快等作用,使致痛物质堆积现象迅速得到解除,有利于功能的快速恢复。对消除颈椎增生的疼痛、缓解临床症状取效迅捷,标本兼治,愈后复发率低,且使用方便、无毒副作用、便于推广应用。
具体实施方式
虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
实施例1
一种用于治疗颈椎骨质增生的药物制剂,各成分按照重量比为:
葛根15克,丹参15克,当归20克,川芎20克,红花20克,桃仁15克,元胡15克,千年健15克,羌活15克,乌鞘蛇12克,威灵仙20克,秦艽15克,苏木15克,补骨脂15克,狗脊15克,天麻12克,木防己20克,赤芍20克,地龙20克,鸡血藤20克。
将以上药物制剂制备成膏药贴剂,制备方法如下:
取以上中药按照常规方法进行煎熬,煎熬后药液进行浓缩,浓缩至一定浓度(比重为1:1),冷后加入1-2倍置的乙醇,充分混匀,放置过夜,使其沉淀,次日取其上清液,沉淀物用少量50%-60%乙醇洗净,洗液与滤液合并,减压回收乙醇后,待浓缩至一定浓度时移置放冷处静置一定时间,使沉淀完全,率过,滤液低温蒸发至稠膏状,加入高级使用醋,调制均匀,薄厚均匀地涂抹于医用胶带的胶面。
实施例2
一种用于治疗颈椎骨质增生的药物制剂,各成分按照重量比为:
葛根12克,丹参12克,当归18克,川芎18克,红花18克,桃仁16克,元胡16克,千年健18克,羌活18克,乌鞘蛇12克,威灵仙22克,秦艽12克,苏木12克,补骨脂12克,狗脊12克,天麻12克,木防己15克,赤芍15克,地龙15克,鸡血藤15克。
将以上药物制剂制备成胶囊剂,制备方法如下:
取以上量的中药进行煎熬,煎熬后药液进行浓缩,浓缩至一定浓度(比重为1:1.2左右),冷后加入1-2倍置的乙醇,充分混匀,放置过夜,使其沉淀,次日取其上清液(必要时滤过),沉淀物用少量50%-60%乙醇洗净,洗液与滤液合并,减压回收乙醇后,待浓缩至一定浓度时加一定量水.混匀静置一定时间,使沉淀完全,率过,滤液低温蒸发至稠膏状,干燥浸膏粉末中加入适宜的辅料蔗糖、预胶化淀粉、羧甲淀粉钠,混匀后,筛分至适合粒度后,填充到空胶囊中即得。
实施例3
一种用于治疗颈椎骨质增生的药物制剂,各成分按照重量比为:
葛根6克,丹参6克,当归15克,川芎15克,红花15克,桃仁10克,元胡
10克,千年健10克,羌活10克,乌鞘蛇10克,威灵仙15克,秦艽8克,苏木6克,补骨脂10克,狗脊9克,天麻10克,木防己12克,赤芍12克,地龙12克,鸡血藤12克。
将以上药物制剂制备成片剂,制备方法如下:
取以上量的中药进行煎熬,煎熬后药液进行浓缩,浓缩至一定浓度(比重为1:1左右),冷后加入1.1倍置的乙醇,充分混匀,放置过夜,使其沉淀,次日取其上清液(必要时滤过),沉淀物用少量52%乙醇洗净,洗液与滤液合并,减压回收乙醇后,待浓缩至一定浓度时加一定量水.混匀静置一定时间,使沉淀完全,率过,滤液低温蒸发至稠膏状,干燥浸膏粉末中加入适宜的糊精、预胶化淀粉、硬脂酸镁、辅料,混匀后,加压成逐步整到符合要求的粒度,进行压片,得片剂。
实施例4
一种用于治疗颈椎骨质增生的药物制剂,各成分按照重量比为:
葛根18克,丹参18克,当归30克,川芎30克,红花30克,桃仁20克,元胡20克,千年健20克,羌活20克,乌鞘蛇15克,威灵仙25克,秦艽18克,苏木18克,补骨脂20克,狗脊20克,天麻15克,木防己20克,赤芍25克,地龙25克,鸡血藤25克。
将以上药物制剂制备成散剂,制备方法如下:
以上量的中药按照常规方法进行煎熬,煎熬后药液进行浓缩至比重为1:1.2的浓度,冷后加入1.5倍置的乙醇,充分混匀,放置过夜,使其沉淀,次日取其上清液,沉淀物用少量50%乙醇洗净,洗液与滤液合并,减压回收乙醇后,待浓缩至一定浓度时移置放冷处静置一定时间,使沉淀完全,率过,滤液低温蒸发至稠膏状,干燥浸膏粉末中加入适宜的淀粉和磷酸钙辅料,混匀后,过200目筛,即得散剂。
实施例5:临床实验
5.1一般资料
收治2013年6月到2015年5月期间因患颈椎骨质增生病就诊的病人,60例,诊断标准表现为颈部、肩部、背部的疼痛、不适及及颈椎不稳定的表现,部分患者感到脑后部有疼痛及麻木感,X线片显示有椎体前缘骨质增生。60例病例中,男性32例,年龄28-62岁,平均年龄45岁;女性28例,年龄27-68岁,平均年龄47岁,病程2周-10年,其中X片显示:1个-2个椎体骨质增生27例,3个~4个椎体骨质增生24例,颈椎变直18例。
5.2治疗方案
该临床试验中的患者分为3组,分别为,口服药物组,外用+口服组,外用药物组,其中每个组随机分20例患者,10天为一个疗程。
口服药物组,按照一副一日的剂量服用本发明中的药物制剂;
外用药物组,在颈椎部位使用实施例1的膏药贴剂,每日两贴;
外用+口服组,服用口服药物组的药物制剂,同时外用膏药贴剂。
5.3疗效标准
治愈:经1个~3个疗程治疗,临床症状、体征消失,活动自如,观察1个月内未复发者;
显效:经1个~3个疗程治疗,临床症状、体征基本消失,1月内偶有反复者;
有效:经1个~3个疗程治疗,临床症状基本消失,停药后仍有反复,但自觉症状明显减轻为好转;
无效:经1个~3个疗程治疗,临床症状、体征无明显改善者。
总有效率:(治愈+显效+有效)/患病个体
5.4治疗结果
结果见表1,经统计学分析,三组进行比较,内服加外用的外用+口服组在显效率上高于口服药物组和外用药物组,内服的口服药物组与外用药物组相比,其显效的病例数低于外用的药物组,说明该药物外用的疗效更为直接,具有显著性差异(P<0.05)。
表1三组药物的治疗结果
| 组别(20人) | 治愈 | 显效 | 有效 | 无效 | 显效率 |
| 口服药物组 | 1 | 7 | 11 | 1 | 95.0% |
| 外用药物组 | 1 | 10 | 8 | 1 | 95.0% |
| 外用+口服组 | 2 | 12 | 6 | 0 | 100.0% |
5.5典型病例
病例1
桑某,男,56岁,患颈椎病5年,颈椎,肩部不适,头颈活动时有响声,伴有头晕,头痛,眼花咽闷,肩背胀痛及上肢麻木刺痛,头颈活动时加剧,唇舌紫暗或有瘀斑,X片显示有增生的椎体,治疗方案为本发明的药物制剂的内服+外用疗法,内服为自己煎熬汤剂,外用为一日两贴,治疗1个疗程后,症状减轻,继续治疗2个疗程,临床症状基本消失,观察一个月未见复发,且治疗期间及观察期,出因贴膏药而颈部发红,微痛(停药即消失)外,无任何不适症状,判定为治愈。
病例2
赵某,女,41岁,办公室职员,面对电脑时间较多,颈部不适有一年半,症状为:颈部强直,转动不便,伴有响声,肩臂与上肢酸麻冷痛,畏寒怕风,每遇风寒及阴雨时症状加剧,舌苔白,脉浮紧。X片显示,有1个增生的椎体,治疗方案为服用实施例3中的片剂,治疗2个疗程后,症状有缓解,继续治疗3个疗程,症状基本消失,观察两个月未见复发,且治疗期间及观察期无任何不是症状。
Claims (7)
1.一种用于治疗颈椎骨质增生的药物制剂,其特征在于:按照重量分数比包括:葛根6-18份,丹参6-18份,当归15-30份,川芎15-30份,红花15-30份,桃仁10-20份,元胡10-20份,千年健10-20份,羌活10-20份,乌鞘蛇10-15份,威灵仙15-25份,秦艽8-18份,苏木6-18份,补骨脂10-20份,狗脊8-20份,天麻10-15份,木防己12-25份,赤芍12-25份,地龙12-25份,鸡血藤12-25份。
2.根据权利要求1所述的药物制剂,其特征在于:按照重量分数比包括:葛根15份,丹参15份,当归20份,川芎20份,红花20份,桃仁15份,元胡15份,千年健15份,羌活15份,乌鞘蛇12份,威灵仙20份,秦艽15份,苏木15份,补骨脂15份,狗脊15份,天麻12份,木防己20份,赤芍20份,地龙20份,鸡血藤20份。
3.根据权利要求1所述的药物制剂,其特征在于:按照重量分数比包括:葛根12份,丹参12份,当归18份,川芎18份,红花18份,桃仁16份,元胡16份,千年健18份,羌活18份,乌鞘蛇12份,威灵仙22份,秦艽12份,苏木12份,补骨脂12份,狗脊12份,天麻12份,木防己15份,赤芍15份,地龙15份,鸡血藤15份。
4.根据权利要求1-3所述的药物制剂,其特征在于,所述的药物制剂在制备治疗颈椎骨质增生药物中的应用。
5.根据权利要求1-3所述的药物制剂,其特征在于,所述药物制剂制备成膏药贴剂。
6.根据权利要求5所述的药物制剂,其特征在于:所述膏药贴剂用食醋调制膏剂。
7.根据权利要求1-3所述的药物制剂,其特征在于,所述药物制剂制备成颗粒剂,散剂,胶囊剂,丸剂,片剂以及临床上可接受的剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610013359.1A CN105412626A (zh) | 2016-01-10 | 2016-01-10 | 一种用于治疗颈椎骨质增生的药物制剂及其用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610013359.1A CN105412626A (zh) | 2016-01-10 | 2016-01-10 | 一种用于治疗颈椎骨质增生的药物制剂及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105412626A true CN105412626A (zh) | 2016-03-23 |
Family
ID=55491469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610013359.1A Pending CN105412626A (zh) | 2016-01-10 | 2016-01-10 | 一种用于治疗颈椎骨质增生的药物制剂及其用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105412626A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511905A (zh) * | 2016-12-20 | 2017-03-22 | 广州聚澜健康产业研究院有限公司 | 一种用于治疗颈椎病的中药制剂及其制备方法 |
| CN107788768A (zh) * | 2017-10-31 | 2018-03-13 | 肖燕萍 | 颈椎护颈枕中药配方 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732432A (zh) * | 2008-11-20 | 2010-06-16 | 艾永平 | 一种用于抗骨质增生的中药 |
| CN103599353A (zh) * | 2013-11-15 | 2014-02-26 | 武汉新国峰科技开发有限公司 | 一种抑制安神中成药及其制备方法 |
-
2016
- 2016-01-10 CN CN201610013359.1A patent/CN105412626A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732432A (zh) * | 2008-11-20 | 2010-06-16 | 艾永平 | 一种用于抗骨质增生的中药 |
| CN103599353A (zh) * | 2013-11-15 | 2014-02-26 | 武汉新国峰科技开发有限公司 | 一种抑制安神中成药及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 吴震西等: "活血通络汤治疗神经根型颈椎病58例小结", 《实用中医内科杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511905A (zh) * | 2016-12-20 | 2017-03-22 | 广州聚澜健康产业研究院有限公司 | 一种用于治疗颈椎病的中药制剂及其制备方法 |
| CN107788768A (zh) * | 2017-10-31 | 2018-03-13 | 肖燕萍 | 颈椎护颈枕中药配方 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547790A (zh) | 一种治疗风湿性关节炎的中药组合物及其制备方法 | |
| CN103463356A (zh) | 治疗阳虚痹症的中药组合物 | |
| CN102366541B (zh) | 一种治疗消渴病的中药组合物 | |
| CN101897882B (zh) | 一种治疗乳腺小叶增生及囊肿的药物 | |
| CN103191382B (zh) | 一种治疗痹症的药物及其制备方法 | |
| CN103720851B (zh) | 一种治疗骨质增生的中药汤剂 | |
| CN103599404A (zh) | 一种治疗颈椎病的中药汤剂 | |
| CN102423433A (zh) | 一种用于治疗银屑病的中药混合物 | |
| CN106265999A (zh) | 一种治疗颈椎病、腰椎病的丸剂药物及制备方法 | |
| CN105412626A (zh) | 一种用于治疗颈椎骨质增生的药物制剂及其用途 | |
| CN101322756B (zh) | 用于推拿按摩治疗腰椎病症的药物及其制备方法 | |
| CN104857311A (zh) | 一种治疗缺血性股骨头坏死的中药 | |
| CN103550383A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN102579613A (zh) | 治疗风湿伤痛的内服中药组合物 | |
| CN102406893A (zh) | 一种治疗银屑病的中成药 | |
| CN102872413A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN103202985A (zh) | 治疗腰椎、颈椎、坐骨神经、风湿病的中药及其制备方法 | |
| CN106138436A (zh) | 一种治疗腰椎间盘突出和骨质增生的中药及其制备方法 | |
| CN104815017A (zh) | 一种治疗骨质增生的中药软膏及其制备方法 | |
| CN104667129B (zh) | 一种治疗风湿性心脏病的药物 | |
| CN102423458A (zh) | 一种用于治疗银屑病的中成药 | |
| CN103263645B (zh) | 一种治疗胃炎、胃溃疡的药物 | |
| CN109806351A (zh) | 颈肩腰腿痛温敷散 | |
| CN101028472B (zh) | 一种内服治疗腰肌劳损的中药组合物 | |
| CN106344896A (zh) | 一种治疗风湿病、颈椎病和腰椎间盘突出症的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160323 |